Target intelligence / Profile preview

ATP-dependent Clp protease ATP-binding subunit ClpX (Helicobacter pylori) (ClpX)

Target
ClpX
Molecular classification
Enzyme, ATPase, Chaperone, AAA+ ATPase family
01

Overview

ATP-dependent Clp protease ATP-binding subunit ClpX (ClpX) is a vital molecular chaperone and ATPase in Helicobacter pylori that belongs to the AAA+ (ATPases Associated with diverse cellular Activities) family (UniProt P56001). It functions by recognizing, unfolding, and translocating specific protein substrates into the ClpP protease chamber for degradation, thereby maintaining bacterial proteostasis and supporting survival under stress (Sun et al., Chem. Sci., 2015). In the context of H. pylori treatment, ClpX has been identified as a primary molecular target for bismuth-based drugs, such as bismuth subcitrate potassium. Bismuth ions (Bi3+) exert their antibacterial effect by binding to the highly conserved zinc-binding domain of ClpX, displacing the essential zinc ion and triggering the irreversible disassembly of the active hexameric enzyme (Yuan et al., Metallomics, 2020). This inhibition disrupts the bacterial protein quality control system, contributing to the eradication of the pathogen in patients with peptic ulcers or chronic gastritis (Wang et al., J. Inorg. Biochem., 2018).

Other names
ClpX chaperoneATP-dependent Clp protease subunit ClpXH. pylori ClpXAAA+ ATPase ClpX
02

Mechanism of action

Bismuth ions (Bi3+) bind to the highly conserved N-terminal zinc-binding domain (ZBD) of ClpX, displacing the native zinc ion (Zn2+). This displacement causes the irreversible disassembly of the functional hexameric ClpX complex, thereby inhibiting its ATPase and chaperone activities and disrupting bacterial protein homeostasis (Sun et al., Chem. Sci., 2015; Yuan et al., Metallomics, 2020).

03

Biological functions

Protein degradationProtein foldingStress responseProteostasisATP hydrolysis
04

Disease associations

InfectionPeptic ulcer diseaseGastric cancerGastritis
05

Safety considerations

Bismuth-induced encephalopathy (associated with chronic high-dose use)Gastrointestinal side effects such as nausea and abdominal painHarmless blackening of stool and tonguePotential for neurotoxicity in patients with renal impairment
06

Interacting drugs

Bismuth subcitrate potassium

3 more in the full profile.

07

Biomarkers

13C-Urea breath testH. pylori stool antigenRapid urease test (RUT)

Beyond the preview

Go deeper on ATP-dependent Clp protease ATP-binding subunit ClpX (Helicobacter pylori) (ClpX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-dependent Clp protease ATP-binding subunit ClpX (Helicobacter pylori) (ClpX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call